Journal
DIABETES
Volume 70, Issue 8, Pages 1898-1909Publisher
AMER DIABETES ASSOC
DOI: 10.2337/db21-0066
Keywords
-
Categories
Funding
- Rutherford Chair, Baylor St. Luke's Medical Center/Baylor College of Medicine
- National Institutes of Health [RO1 DK101411]
- Agricultural Research Service, U.S. Department of Agriculture [58-6250-6001]
Ask authors/readers for more resources
Patients with A-beta+ ketosis-prone diabetes (KPD) during diabetic ketoacidosis (DKA) show metabolic similarities to type 1 diabetes (T1D) patients, including impaired branched-chain amino acid (BCAA) catabolism and accelerated fatty acid flux to ketones. The natural history of A-beta+ KPD is characterized by chronic but varying dysregulation of BCAA metabolism.
When stable and near-normoglycemic, patients with A-beta+ ketosis-prone diabetes (KPD) manifest accelerated leucine catabolism and blunted ketone oxidation, which may underlie their proclivity to develop diabetic ketoacidosis (DKA). To understand metabolic derangements in A-beta+ KPD patients during DKA, we compared serum metabolomics profiles of adults during acute hyperglycemic crises, without (n = 21) or with (n = 74) DKA, and healthy control subjects (n = 17). Based on 65 kDa GAD islet autoantibody status, C-peptide, and clinical features, 53 DKA patients were categorized as having KPD and 21 type 1 diabetes (T1D); 21 nonketotic patients were categorized as having type 2 diabetes (T2D). Patients with KPD and patients with T1D had higher counterregulatory hormones and lower insulin-to-glucagon ratio than patients with T2D and control subjects. Compared with patients withT2D and control subjects, patients with KPD and patients with T1D had lower free carnitine and higher long-chain acylcarnitines and acetylcarnitine (C2) but lower palmitoylcarnitine (C16)-to-C2 ratio; a positive relationship between C16 and C2 but negative relationship between carnitine and beta -hydroxybutyrate (BOHB); higher branched-chain amino acids (BCAAs) and their ketoacids but lower ketoisocaproate (KIC)-to-Leu, ketomethylvalerate (KMV)-to-Ile, ketoisovalerate (KIV)-to-Val, isovalerylcarnitine-to-KIC+KMV, propionylcarnitine-to-KIV+KMV, KIC+KMV-to-C2, and KIC-to-BOHB ratios; and lower glutamate and 3-methylhistidine. These data suggest that during DKA, patients with KPD resemble patients with T1D in having impaired BCAA catabolism and accelerated fatty acid flux to ketones-a reversal of their distinctive BCAA metabolic defect when stable. The natural history of A-beta+ KPD is marked by chronic but varying dysregulation of BCAA metabolism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available